Kyongsik Yun received a BS (2006) and a PhD (2010) in brain engineering at the Korea Advanced Institute of Science and Technology (KAIST). Yun then moved to the California Institute of Technology (Caltech), where he published two innovative Nature papers on artificial telepathy and noninvasive neural network modulation. Yun co-founded two biotech companies, Ybrain (2012) and BBB (2015) that raised $9.8M. He continues working on developing novel technologies for the early diagnostics and the treatment of brain disorders. Yun’s pioneering technology has far-reaching implications for the future of human brain health. It is set to play an integral role in the treatment of brain disorders such as Parkinson’s disease, autism and psychiatric illnesses. He believes that this safe, effective and mobile technology will revolutionize brain science and the medical industry.